(Q34933436)

5 August 2017

1 reference

title

Genetic susceptibility to ageing-associated diseases (English)

1 reference

5 August 2017

Philippe Amouyel

1

0 references

publication date

1 June 2002

1 reference

Comptes Rendus. Biologies

5 August 2017

published in

1 reference

5 August 2017

volume

325

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

741-745

1 reference

Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

Aging, natural death, and the compression of morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

Epidemiological methods for studying genes and environmental factors in complex diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

Parental history of early myocardial infarction is associated with decreased levels of lipoparticle AI in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

Multifactorial qualitative traits: genetic analysis and prediction of recurrence risks

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

Interpretation of results from genetic studies of multifactorial diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

Apolipoprotein E polymorphism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

Human apolipoprotein E: the Alzheimer's disease connection.

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

Epidemiology of eye disease in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

Genetic association of apolipoprotein E with age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

Distortion of allelic expression of apolipoprotein E in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

A critical assessment of the role of pharmacogenomics and pharmacogenetics approaches to cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

Pharmacogenomics and pharmacogenetics of neurodegenerative diseases: towards new targets.

1 reference

https://api.crossref.org/works/10.1016%2FS1631-0691%2802%2901481-6

7 January 2021

10.1016/S1631-0691(02)01481-6

Identifiers

DOI

1 reference

5 August 2017

1 reference